Alpha-2A Adrenergic Receptor (ADRA2A) Peptide
-
- Target See all ADRA2A products
- ADRA2A (Alpha-2A Adrenergic Receptor (ADRA2A))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP)
- Characteristics
- The peptide is used to block Anti-Alpha-2A Adrenergic Receptor Antibody reactivity.
-
-
- Application Notes
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Storage
- -20 °C
- Storage Comment
- Shipped at 4°C. Store at -20°C for one year.
- Expiry Date
- 12 months
-
- Target
- ADRA2A (Alpha-2A Adrenergic Receptor (ADRA2A))
- Synonyms
- ADRA2A Peptide, AW122659 Peptide, Adra-2 Peptide, Adra-2a Peptide, alpha(2A)AR Peptide, alpha2-C10 Peptide, alpha2A Peptide, alpha2A-AR Peptide, ADRA2 Peptide, ADRA2R Peptide, ADRAR Peptide, ALPHA2AAR Peptide, ZNF32 Peptide, CA2-47 Peptide, RATRG20 Peptide, RG20 Peptide, PORA2AR Peptide, adrenoceptor alpha 2A Peptide, alpha-2A adrenergic receptor-like Peptide, adrenergic receptor, alpha 2a Peptide, adra2a Peptide, ADRA2A Peptide, LOC100414445 Peptide, Adra2a Peptide
- Background
- ADRA2R, ADRAR, Alpha-2A adrenergic receptor, Alpha-2 adrenergic receptor subtype C10, Alpha-2A adrenoreceptor, Alpha-2A adrenoceptor, Alpha-2AAR
- Gene ID
- 150
- UniProt
- P08913
-